Labels

Monday, September 29, 2014

Drug Gives Big Survival Boost Against Type of Advanced Breast Cancer

Women with HER2-positive tumors gained an average 16 more months of life with Perjeta, study finds



from WebMD Health http://ift.tt/1ortv83

via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)